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Summary
Objective: Novel approaches to intervention in joint diseases consist of the replacement of diseased cartilage by in vitro engineered, viable
cells or graft tissues. Two major obstacles remain to be overcome: (1) Hyaline cartilage in vitro often loses differentiated traits. (2) Grafts
frequently are not integrated satisfactorily into host cartilage and/or the tissue is remodelled in situ into functionally inferior fibrocartilage.
Therefore, we have explored the possibility whether chondrocytes embedded into agarose gels provided better graft tissues in a repair model
of full thickness defects in rabbit joint cartilage.
Design: Experimental defects of knee joint cartilage was filled with articular chondrocytes cultured in agarose gels. Chondrocytes in vitro
either remained unstimulated or were treated with several growth factors. Repair of the defects was assessed by histology and was scored
between 0 (no healing) and 1 (perfect healing) as judged by the follwing parameters: intensity of proteoglycan staining, organization of the
superficial zone, ossification at the border between repair cartilage and subchondral bone, tidemark formation in the repaired area,
arrangement of chondrocytes, and integration of repair cartilage into host.
Results: Treatment of chondrocyte cultures with bFGF had a stabilizing effect on the differentiated state of the cells in implanted grafts
whereas bone morphogenetic proteins stimulated ingrowth of subchondral bone reducing repair cartilage thickness and preventing normal
tide mark formation; TGF- did not significantly affect evaluation parameters in comparison with untreated controls.
Conclusion: Growth factor treatment resulted in an ambiguous quality of graft development. Only FGF had a clear beneficial effect to the graft
tissues after 1 month. Further studies are required to define the precise conditions and sequence of growth factor treatment of in vitro
engineered cartilage which benefits graft quality. © 2001 OsteoArthritis Research Society International
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Various methods to repair injured articular cartilage in
patients are currently under investigation1–8. While
respectable progress has been made with restitution of
focal cartilage defects by reimplantation of autologous
chondrocytes expanded ex vivo, tissue engineers are still
far away from the goal to substitute cartilage destroyed by
osteoarthritis or rheumatoid arthritis. Further comprehen-
sive studies in animal models will be required to test the
suitability of various methods, solve fundamental problems
of chondrocyte differentiation and cartilage matrix reconsti-
tution as well as problems of implant integration and
stability.
Here we report on the use of chondrocytes cultured in
agarose to heal focal defects artificially set in rabbit articu-
lar cartilage9. The agarose culture system was chosen
because chondrocytes have been shown to maintain their
characteristic phenotype in agarose gel cultures for at least
4 passages10,11. Previously we have demonstrated thatS48transplantation of allograft chondrocytes embedded in
agarose gels into cartilage defects of rabbits allowed com-
plete reconstitution of hyaline articular cartilages in some
cases. Maintenance of the intact hyaline cartilage structure
was seen as long as 1Y years after implantation, while
complete repair was never seen under control conditions9.
However, the results showed a high diversity, and not in all
cases a stable hyaline-like cartilage were highly variable.
Therefore in the present study attempts were made to
stimulate chondrocytes in vitro by the growth factors basic
fibroblast growth factor (bFGF), transforming growth factor
(TGF)-1, and bone morphogenetic proteins in order to
enhance chondrogenic differentiation and to stabilize the
cartilage phenotype in the graft before transplantation. The
quality of the repair tissue was analysed by histological and
immunohistochemical methods as done previously9. The
success of transplantation was evaluated by grading tissue
sections according to six histological criteria and compared
with non-stimulated chondrocyte grafts.Address correspondence to: Dr Ju¨rgen Weisser, FSU Jena,
Institute of Pathology, Ziegelmu¨hlenweg 1, D-07743 Jena, FRG.
Tel: +49 3641 933 910; Fax: +49 3641 933 111.
E-mail: weisser@bach.med.uni-jena.deMaterials and methods
Isolation, cultivation, and transplantation of chondro-
cytes were performed as previously described9 with minor
modifications.
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Articular cartilage prepared from femoral heads of 6- to
8-week-old rabbits (Chinchilla bastard) was cut in small
pieces. The chondrocytes were isolated by sequential
digestion with pronase E from Streptomyces griseus
(Serva, Heidelberg, Germany) (2 mg/g cartilage, 30 min,
37°C) and with collagenase from Clostridium histolyticum
(Serva) (1 mg/g cartilage, 8 h, 37°C). Liberated cells were
washed and resuspended in Ham’s F12 medium. The
isolated chondrocytes were cultured in agarose as
described10,11. Briefly, 40-mm Petri dishes were coated
with a thin layer of 1% agar (Difco, Detroit, USA). Then 2%
agarose of high electroendosmosis (Serva) was equili-
brated to 37°C after autoclaving and an equal volume of
Ham’s F12 medium containing 100 units/ml penicillin and
100 g/ml streptomycin was added. This solution was
mixed with one volume part of cell suspension to yield a
final density of 1.5×106 cells/ml and added to the pre-
coated Petri dishes. After gelation at 4°C for 10 min the
embedded cells were overlayed with Ham’s F12 medium
supplemented with antibiotics and 1 mM cysteine12. The
cells grew to a density of about 2.5×106 cells/ml for further
10 to 14 days in a humidified atmosphere with 5% CO2.
Every 2 days the medium was renewed by the above-
mentioned medium containing 2% fetal calf serum. In
stimulation experiments growth factors were added to the
cells as part of the medium: 5 ng/ml bFGF (from bovine
brain) (R&D Systems, Wiesbaden, Germany), 10 ng/ml
TGF-1 (from porcine platelets) (R&D Systems), and
100 g/ml BMP (guanidine hydrochloride extract of bovine
bone, generous gift of Prof. W. Sebald, University of
Wu¨rzburg), respectively.TRANSPLANTATION OF CHONDROCYTES
Animals were anaesthetized with 4 ml of a mixture of
0.5% xylazine, 7.5% ketamine i.m.; if necessary 0.5 ml
0.2% xylazine, 3% ketamine in physiological salt were
added i.v. Full-thickness articular surface defects of 3 mm
diameter completely penetrating the entire cartilage into the
subchondral bone (1.5 mm depth) were drilled in the medial
and lateral femoral condyles and two defects in the inter-
condylar grooves of adult female Chinchilla bastard rabbits
(nine animals). The area was moistened with antibiotics
(Nebacetin®, Byk Gulden, Konstanz, Germany), a drop of a
fibrin adhesive system (Tissucol-kit®, Immuno, Heidelberg,
Germany) was applied into the defects, which were imme-
diately filled with the chondrocyte-agarose gel. For this
purpose, a small piece of the culture layer of the gel was
cut off some distance from the margin and grafted onto the
defect with the upper side on the surface. Excess material
was removed carefully. The defects of one knee of each
animal were filled with unstimulated chondrocyte-agarose
(controls), the knee of the other side received growth factor
stimulated chondrocyte-agarose. After clot formation the
arthrotomy was closed surgically. A total of 108 control
grafts and 36 grafts of each growth factor were obtained for
transplantation at experimental time points of 1, 3, 6, and
12 months, respectively.TISSUE PREPARATION
The rabbits were killed after the indicated time periods
and then the femurs were prepared. The femur heads were
sawn to pieces containing the individual defective areas.The pieces were fixed in 4% paraformaldehyde in phos-
phate buffered saline (PBS) for 2 days, hydrated for 1 day,
decalcified in 10% ethylenediaminetetraacetic acid in PBS
for at least 2 weeks, dehydrated and embedded in
paraplast according to routine methods.HISTOLOGICAL AND IMMUNOHISTOCHEMICAL STAINING
Serial sections of 8 m thickness were cut from the
embedded tissue specimens perpendicular to the articular
surface and mounted onto microscopic slides (Superfrost
Plus, G. Menzel, Braunschweig, Germany). Proteoglycan
staining was performed by toluidine blue and safranin-O13.
For immunohistochemical detections (not performed in all
specimens and hence not quantified by grading score) a
monoclonal mouse antibody against type II collagen from
chicken (CII E8)14, polyclonal antibody against type I
collagen (Southern Biotechnology Associates, USA) and
against cow S-100 (Dako, Denmark) were used. Second-
ary antibodies were peroxidase-conjugated (type II colla-
gen and S-100 detection) or biotin-conjugated followed by
alkaline phosphatase-avidin (type I collagen detection).
Collagen immunohistochemistry was performed as
described9. The procedure was checked for sufficient
cross-reactivity of the primary antibody and specificity of
rabbit type II collagen detection with the aid of tissue
sections of fetal rabbit joints as substrate. Detection of
S-100 followed the standard procedure of the manufacturer
including a 30 min digestion with 0.1 mg/ml pronase E from
Streptomyces griseus (Serva) after the deparaffination.ANALYSIS OF HISTOLOGICAL PREPARATIONS
Specimens were evaluated in detail by the following six
different restitution parameters: proteoglycan staining,
character of the superficial zone, ossification/border
between repair cartilage and subchondral bone, tidemark
in the repaired area, arrangement of chondrocytic cells,
merging of repair cartilage with adjacent residual cartilage
(modified after Ref. 15). The specimens were scored on a
scale of 0 to 1 (0–100%) for each parameter; perfect
healing of a defect would be characterized by a value of
1.0. For overall assessment the total score was estimated
as the mean of all single scores. Means and standard
errors of each criterion were estimated within the different
experimental groups. Details of the gading by score were
described elsewhere9.STATISTICS
Differences between means were examined on stat-
istical significance by nonparametric Mann-Whitney (U)
test. A significance level of P<0.05 was required.Results
Sections of 197 cartilage defects set in rabbit knee joints
(97 control grafts, 36 bFGF stimulated, 33 BMP stimulated,
and 31 TGF-1 stimulated grafts) were examined after 1, 3,
6, and 12 months using histological and immunohistologi-
cal methods, and the healing process was evaluated
according to the six paprameters described in Materials
and methods. About half of the samples presented
condylar defects, the other half patellar grooves.
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After in vitro stimulation of the chondrocytes with growth
factors only few specific effects were observed in the
histological and immunohistological picture of the repair
tissue. Mainly there were differences of degree.BMP-TREATED CHONDROCYTES
The cartilage specimens obtained during the first 6
months revealed predominantly large, hypertrophic appear-
ing chondrocytes and tissue defects; some of them were
probably sectional artefacts in cases of starting ossification.
Often a heterogenous cellular arrangement was found.
After 12 months BMP-stimulated grafts showed more
inferior results than the corresponding control graft in about
75% of cases. Ossification of parts of the repair cartilage
was more pronounced in comparison with animals without
stimulated transplants (Fig. 1E).FGF-TREATED CHONDROCYTES
The bFGF-stimulated grafts developed into cartilaginous
tissues of high to normal cell density. At 3 to 6 months after
transplantation the repair tissue was characterized by
dense, homogenously distributed cells, but also aggre-
gates of chondrocytes were found. At the type II collagen
negative surface the cells produced type I collagen
predominatly (Fig. 1B).TGF-1 TREATED CHONDROCYTES
The healing process was promoted by TGF-1 without
producing major characteristic alterations compared with
control grafts. After gross evaluation including all six
parameters, at 3 months the TGF--treated specimens
showed results that typically were found in 6 months
samples of the unstimulated chondrocytes. The chondro-
cytes were homogenously distributed in a type II collagen
positive matrix. Only a weak superficial zone showed type I
collagen immunoreactivity in the best healing results
(Fig. 1C, D). However, between 6 and 12 months the
quality of the repair tissues leveled off between stimulated
and control group.
Common problems of articular cartilage repair in all
growth factor stimulated and unstimulated chondrocyte
implants were cartilage fibrillation, degeneration of the joint
surface, insufficient connection to the adjacent normal
cartilage, loss of type II collagen and cartilage specific
proteoglycans; furthermore, uncontrolled ossification per-
sisted after stimulation by growth factors (Fig. 1A–F).GROSS EVALUATION
The gross evaluation which included grading according
to all six parameters revealed a statistically significant
improvement of the healing process only up to 1 month in
bFGF-treated chondrocyte implants in comparison with
unstimulated controls (Fig. 2G). Stimulation of chondro-
cytes by BMP caused significantly lower scores in all
parameters evaluated and resulted in impaired healing at 6
and 12 months compared with unstimulated chondrocytes
(Fig. 2B–F).The effects of growth factor pretreatment on the individ-
ual parameters varied considerably. The ossification pro-
cess was hardly affected by FGF or TGF- (Fig. 2A) and
resulted in high scores. In general, ingrowth of bone into
the original defect gap occured after prolonged time and
closed the cleft at the bottom. The main complication
consisted in the continuation of bone growth from the deep
zone to the surface, thus narrowing the zone of repair
cartilage. Although there was no statistically significant
influence of BMP on this process, enhanced ossification
was most prominent in single BMP-treated samples. Low
deviations and scores greater 0.7 show that bone ingrowth
is controlled by relatively robust mechanisms.
In contrast, the formation of a tidemark and the lateral
merging of the graft showed a high diversity. The tidemark
was rarely restituted and its formation was nearly
completely prevented by BMP (Fig. 2F).
A particular problem was seen in the difficulty of stimu-
lated chondrocytes to further differentiate and to arrange in
an ordered manner within the defect. In addition to other
histological and immunohistological parameters, the detec-
tion of S-100 immunoreactivity as an early and sensitive
marker of chondrocytic differentiation and dedifferenti-
ation16,17 has proved to be particularly useful for this
evaluation (Fig. 1A). The formation of chondrons remained
insufficient. Their ability to correct heterogenous cell
alignments was obviously limited.
Among the three growth factors tested, only bFGF pro-
duced better results in the total score (Fig. 2G). This
improvement was most significant in 1 month samples,
indicating an acceleration of the development and integra-
tion of the grafts. Basic FGF generally improved the cellular
arrangement (Fig. 2C), although a statistical significance
was not evident. A similar positive effect of bFGF was seen
regarding the quality of the superficial zone (Fig. 2E).
Further studies are necessary to validate long-term effects
of bFGF.
Statistically, the in vitro incubation of the chondrocyte
cultures with the growth factors BMP and TGF-1 did not
improve the healing results in comparison with untreated
control grafts.Discussion
Current procedures of cartilage healing that are based
on, a method described by Brittberg et al.18 receive
increasing acceptance among clinicians and patients. The
method includes grafting of autologous chondrocytes, har-
vested from non-weight bearing areas and expanded
in vitro, and reinjection into the cartilage defect under a
periosteal flap. However, the method is limited to local
cartilage defects, and there is still some debate concerning
efficiency, quality of the reconstituted cartilage, integration
into the host tissue and persistence19. The fate of the
injected chondrocytes remained unclear, whereas various
studies observed chondrogenic differentiation in periosteal
grafts without implanted chondrocytes5,8,20. The peri-
chondrium itself undergoes chondrogenesis, but may also
contribute to chondrogenic differentiation of the grafted
cells by producing growth and differentiation factors, which
play an important role in this process.
In a previous study on the reimplantation of chondro-
cytes embedded in agarose it became apparent that
grafted chondrocyte differentiate into most divergent man-
ner in the defect9. Besides the synthesis of the cartilage
Osteoarthritis and Cartilage Vol. 9 Suppl. A S51Fig. 1. Microphotographs of cartilage defects after transplantation of chondrocyte agarose grafts and immunohistological detection of protein
S-100 (A) or type I collagen (B–F) illustrating different healing results. (A) S-100 immunopositive chondrocytes were found in the normal
cartilage above the tidemark and the core of the repair tissue 6 months after transplantation of untreated chondrocytes. Cells in the zone of
lateral connection and at the surface of the defect are S-100 negative and obviously damaged. Overview, 15×. (B) Repair tissue (at the left)
and adjacent cartilage (at the right) 6 months after transplantation of bFGF-treated chondrocytes. Only an inferior lateral connection was
produced (cleft). The type I collagen content increased at the surface. Some cell aggregates were formed and partially a vertical alignment
was visible. Detail 60×. (C, D) Defect 3 months after transplantation of TGF-1-treated chondrocyte grafts. Although the original margin of
the defect persisted in the depth a stable lateral merging was generated with the exception of the mineralized cartilage. Cells in the restituted
zone are smaller than in adjacent cartilage but produced extracellular matrix rich of type II collagen and proteoglycan (not shown). A tidemark
was not formed. Overview 15× (C), detail 60× (D). (E) Defect 6 months after transplantation of BMP-treated chondrocyte grafts. Most of the
graft was substituted by bone. Only a thin layer of residual cartilaginous tissue marks the original defect in the depth (white arrow). Overview,
15×. (F) 3 months after transplantation of BMP-treated chondrocyte grafts the repair tissue (at the left) is rich of cells of different sizes and
shows a high content of type I collagen. Detail 60×.specific components such as type II collagen and aggre-
can, chondrocytes would have to arrange and differentiate
according to their location in the repair tissue in relation to
the adjacent tissue. Integration of the graft requires not only
formation of cartilage but also its early remodelling, particu-larly at the margins. Here we have investigated whether
healing results could possibly be improved when chondro-
cytes were stimulated with growth factors that might
promote redifferentiation and remodeling. Growth factors of
the TGF- superfamily and others are known to participate
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Fig. 2. Evaluation of the quality of the repair cartilage according to different parameters and resulting total score at different time points.
Columns represent unstimulated, bFGF, BMP, and TGF-1 stimulated chondrocyte grafts, respectively (from the left to the right). Significant
differences between stimulated and unstimulated grafts are marked by asterisks. Bars reflect the standard error of the mean. Content of
proteoglycan of the TGF-1 group was not significantly reduced at 12 months because of low number (n=3) of evaluable cases.
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processes. BMPs are important signalling molecules for
limb bud development during embryogenesis21,22, ectopi-
cally induce bone formation23; they are also expressed
during bone fracture healing24,25 and control the differen-
tiation of diverse mesenchymal cells, particularly
osteoblasts and chondrocytes in vitro26–29.
In our transplantation experiments BMP-stimulated ossi-
fication was observed in about 20% of all specimens; the
increase in bony tissue was largely due to ingrowth from
adjacent bone. Statistically the increase in ossification was
not evident since low scores were attributed to both
retarded and to excessive ossification. Most likely the
enhanced ossification is a result of BMP-induced osteo-
blast stimulation leading to proliferation and synthesis of
bone matrix on the one hand, and arrest of chondrocyte
proliferation on the other hand. The BMP preparation used
here consisted of a spectrum of BMPs because different
heterodimers were shown to possess full or even higher
biological activity than homodimers30. However, this
approach was not successfull and defined recombinant
proteins should be investigated in future studies, since
different effects were described for different BMPs
in vitro29,31.
It has been shown that TGF-1 maintains epiphyseal
chondrocytes in a prehypertrophic phenotype by maintain-
ing expression of type II collagen and aggrecan core
protein and inhibition of expression of metalloproteases32.
Interestingly, opposite effects were also observed under
different culture conditions illustrating the complex regula-
tion mechanisms of growth and differentiation in bone and
cartilage. Bovine articular chondrocytes modified their rate
of proliferation in culture even when the sequence of
TGF-2 addition, only, was altered33. TGF-1 was reported
to stabilize both anabolic and catabolic functions depend-
ing on the system investigated and the cells involved. In
periosteal cells, TGF-1 supported chondrogenic differen-
tiation and induced synthesis of cartilage specific compo-
nents34,35. By contrast, TGF- has been suggested to
contribute to the degradation of cartilage in arthritis and
osteoarthritis36. Possibly, TGF-1 is less suitable to
improve cartilage repair by completely differentiated
chondrocyte grafts.
In agreement with other reports, the positive effects on
cartilage repair observed in many bFGF treated chondro-
cyte implants may prove to be important. For example,
bFGF has been shown to stabilize the phenotype of mam-
malian chondrocytes by preventing their dedifferentiation in
culture37. In a study on the repair of full-thickness defects of
articular cartilage in rabbits without cell grafting best results
were abtained after application of 700 ng bFGF to the
empty defect38. In the study presented here, bFGF
improved in particular the initial healing phase; however,
the application of bFGF alone did not lead to perfect
structural restitution of the repair tissue to hyaline cartilage.
Further studies will be necessary using combinations of
growth factors and to elaborate a precise, temporally and
spatially controlled application procedure in order to
improve healing results.Acknowledgments
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